Singh Anand K, Sahani Dushyant V
Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA.
Radiol Clin North Am. 2008 Jan;46(1):79-93, vi. doi: 10.1016/j.rcl.2008.01.009.
Renal transplant remains the mainstay of the treatment of end-stage renal disease. With improvement in management strategies and the diverse imaging options, the yearly survival of recipients with functional kidneys has improved significantly. This improved survival is attributed to factors such as immunosuppressive therapy planning in recipients, human leukocyte antigen matching, surgeon experience, and recipient's age. Transplantation offers the closest thing to a normal state if the transplanted kidney can replace the failed kidneys. Living-donor kidney transplants are playing a vital role in bridging the gap between decreased supply of, and increased demand for, kidneys for transplant. Early detection and characterization of complications in the recipient are of immense clinical relevance, allowing timely intervention to prevent graft failure.
肾移植仍然是终末期肾病治疗的主要手段。随着管理策略的改进和多种成像选择,有功能肾脏的受者的年生存率有了显著提高。这种生存率的提高归因于受者免疫抑制治疗方案、人类白细胞抗原匹配、外科医生经验和受者年龄等因素。如果移植的肾脏能够替代衰竭的肾脏,那么移植就能提供最接近正常状态的情况。活体供肾移植在弥合移植肾供应减少和需求增加之间的差距方面发挥着至关重要的作用。对受者并发症的早期检测和特征描述具有巨大的临床意义,能够及时进行干预以防止移植肾失败。